News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,259 Results
Type
Article (13585)
Company Profile (110)
Press Release (247564)
Section
Business (87948)
Career Advice (461)
Deals (15325)
Drug Delivery (64)
Drug Development (36530)
Employer Resources (49)
FDA (6259)
Job Trends (6184)
News (150028)
Policy (14007)
Tag
Academia (435)
Alliances (23097)
Alzheimer's disease (351)
Approvals (6253)
Artificial intelligence (61)
Bankruptcy (143)
Best Places to Work (4325)
Biotechnology (44)
Breast cancer (42)
Cancer (315)
Career advice (405)
Cell therapy (44)
Clinical research (30402)
Collaboration (155)
Compensation (62)
COVID-19 (747)
C-suite (52)
Data (343)
Diabetes (53)
Diagnostics (1236)
Drug pricing (57)
Earnings (31558)
Employer resources (43)
Events (36738)
Executive appointments (173)
FDA (6439)
Funding (108)
Gene therapy (59)
GLP-1 (292)
Government (1266)
Healthcare (3521)
Infectious disease (765)
Inflammatory bowel disease (46)
Interviews (58)
IPO (5818)
Job creations (2049)
Job search strategy (372)
Layoffs (167)
Legal (3411)
Lung cancer (46)
Manufacturing (99)
Medical device (1261)
Medtech (1263)
Mergers & acquisitions (9542)
Metabolic disorders (168)
Neuroscience (449)
NextGen Class of 2024 (1580)
Non-profit (590)
Northern California (433)
Obesity (101)
Opinion (109)
Patents (53)
People (28459)
Pharmaceutical (64)
Phase I (7904)
Phase II (12857)
Phase III (11552)
Pipeline (183)
Policy (45)
Postmarket research (1399)
Preclinical (3165)
Radiopharmaceuticals (116)
Rare diseases (90)
Real estate (2629)
Regulatory (9821)
Research institute (562)
Resumes & cover letters (55)
Southern California (435)
Startups (1625)
United States (4279)
Vaccines (112)
Weight loss (78)
Date
Today (46)
Last 7 days (273)
Last 30 days (1271)
Last 365 days (12709)
2024 (11618)
2023 (14244)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14887)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (42)
Asia (19792)
Australia (2559)
California (1007)
Canada (600)
China (111)
Colorado (42)
Connecticut (42)
Europe (38779)
Florida (152)
Illinois (111)
Indiana (86)
Japan (43)
Kansas (51)
Maryland (155)
Massachusetts (881)
Minnesota (56)
New Jersey (422)
New York (279)
North Carolina (278)
Northern California (433)
Pennsylvania (286)
South America (498)
Southern California (435)
Texas (138)
Virginia (41)
Washington State (71)
261,259 Results for "eyepoint pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
November 5, 2024
·
2 min read
Press Releases
EyePoint Pharmaceuticals Announces Pricing of Upsized Public Offering
October 30, 2024
·
7 min read
Press Releases
EyePoint Pharmaceuticals Announces Proposed Public Offering of Common Stock
October 29, 2024
·
7 min read
Genetown
EyePoint Pharmaceuticals to Host R&D Day on June 26, 2024
EyePoint Pharmaceuticals, Inc. today announced that the Company will host an R&D Day on Wednesday, June 26, 2024 from 8:00 a.m. to 9:30 a.m. ET.
June 18, 2024
·
2 min read
Genetown
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
EyePoint Pharmaceuticals, Inc. today announced that Jay S. Duker, M.D., President and Chief Executive Officer of EyePoint Pharmaceuticals will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024 at 3:20 p.m. ET.
June 5, 2024
·
1 min read
Genetown
EyePoint Pharmaceuticals to Highlight DURAVYUTM (vorolanib intravitreal insert) Clinical and Regulatory Progress and Pipeline Innovation at R&D Day 2024
EyePoint Pharmaceuticals, Inc. today announced the Company will highlight clinical and regulatory developments for its lead pipeline program, DURAVYU™.
June 26, 2024
·
11 min read
Press Releases
EyePoint Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments
November 7, 2024
·
13 min read
Press Releases
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - November 18, 2024
November 19, 2024
·
2 min read
Press Releases
EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
November 1, 2024
·
6 min read
Business
EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments
EyePoint Pharmaceuticals, Inc. announced financial results for the first quarter ended March 31, 2024, and highlighted recent corporate developments.
May 8, 2024
·
11 min read
1 of 26,126
Next
